AI-assisted, human-published
02/15/2024 /Startups/Founders
Firefly Bio Emerges from Stealth Mode with $94M Series A Financing for Cancer Treatment Platform
Firefly Bio, based in South San Francisco, emerges from stealth with $94M Series A financing for its novel platform utilizing degrader antibody conjugates (DACs) to address the limitations of current cancer treatment approaches.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com